Literature DB >> 16985171

Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.

Kevin N Heller1, Jenica Upshaw, Beza Seyoum, Henry Zebroski, Christian Münz.   

Abstract

CD4+ T cells, specific for transforming latent infection with the Epstein Barr virus (EBV), consistently recognize the nuclear antigen 1 of EBV (EBNA1). EBNA1-specific effector CD4+ T cells are primarily T-helper 1 (TH1) polarized. Here we show that most healthy EBV carriers have such IFN-secreting EBNA1-specific CD4+ T cells at a frequency of 0.03% of circulating CD4+ T cells. In addition, healthy carriers have a large pool of CD4+ T cells that proliferated in response to EBNA1 and consisted of distinct memory-cell subsets. Despite continuous antigen presence due to persistent EBV infection, half of the proliferating EBNA1-specific CD4+ T cells belonged to the central-memory compartment (TCM). The remaining EBNA1-specific CD4+ T cells displayed an effector-memory phenotype (TEM), of which a minority rapidly secreted IFN upon stimulation with EBNA1. Based on chemokine receptor analysis, all EBNA1-specific TCM CD4+ T cells were TH1 committed. Our results suggest that protective immune control of chronic infections, like EBV, includes a substantial reservoir of TCM CD4+ TH1 precursors, which continuously fuels TH1-polarized effector cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16985171      PMCID: PMC1785143          DOI: 10.1182/blood-2006-05-023663

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

Authors:  M V Dhodapkar; R M Steinman; M Sapp; H Desai; C Fossella; J Krasovsky; S M Donahoe; P R Dunbar; V Cerundolo; D F Nixon; N Bhardwaj
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

2.  Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line.

Authors:  T Lindahl; A Adams; G Bjursell; G W Bornkamm; C Kaschka-Dierich; U Jehn
Journal:  J Mol Biol       Date:  1976-04-15       Impact factor: 5.469

3.  Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

Authors:  J Levitskaya; M Coram; V Levitsky; S Imreh; P M Steigerwald-Mullen; G Klein; M G Kurilla; M G Masucci
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

4.  A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.

Authors:  L C Tan; N Gudgeon; N E Annels; P Hansasuta; C A O'Callaghan; S Rowland-Jones; A J McMichael; A B Rickinson; M F Callan
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

5.  Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing.

Authors:  R Khanna; S R Burrows; P M Steigerwald-Mullen; D J Moss; M G Kurilla; L Cooper
Journal:  Int Immunol       Date:  1997-10       Impact factor: 4.823

6.  A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle.

Authors:  B C Schaefer; J L Strominger; S H Speck
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Donor T cells to treat EBV-associated lymphoma.

Authors:  H E Heslop; M K Brenner; C M Rooney
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

8.  Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing.

Authors:  N Blake; S Lee; I Redchenko; W Thomas; N Steven; A Leese; P Steigerwald-Mullen; M G Kurilla; L Frappier; A Rickinson
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

9.  Human CD4+ T cells are predominantly distributed among six phenotypically and functionally distinct subsets.

Authors:  Elisabeth Amyes; Andrew J McMichael; Margaret F C Callan
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

10.  Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.

Authors:  C Münz; K L Bickham; M Subklewe; M L Tsang; A Chahroudi; M G Kurilla; D Zhang; M O'Donnell; R M Steinman
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

View more
  23 in total

Review 1.  Immune modulation during latent herpesvirus infection.

Authors:  Douglas W White; R Suzanne Beard; Erik S Barton
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

2.  Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis.

Authors:  J Scherrenburg; E R W A N Piriou; N M Nanlohy; D van Baarle
Journal:  Clin Exp Immunol       Date:  2008-06-28       Impact factor: 4.330

Review 3.  Immunotherapy targeting EBV-expressing lymphoproliferative diseases.

Authors:  Catherine M Bollard; Laurence J Cooper; Helen E Heslop
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

Review 4.  Heterogeneous memory T cells in antiviral immunity and immunopathology.

Authors:  David Verhoeven; John R Teijaro; Donna L Farber
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

5.  Persistent gamma-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations.

Authors:  Kathleen A Stuller; Stephanie S Cush; Emilio Flaño
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

6.  Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults.

Authors:  D Cárdenas Sierra; G Vélez Colmenares; A Orfao de Matos; S Fiorentino Gómez; S M Quijano Gómez
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

Review 7.  Immune escape by Epstein-Barr virus associated malignancies.

Authors:  Christian Münz; Ann Moormann
Journal:  Semin Cancer Biol       Date:  2008-10-19       Impact factor: 15.707

8.  Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD.

Authors:  Angela Mensen; Il-Kang Na; Ralf Häfer; Astrid Meerbach; Maria Schlecht; Marie-Luise Pietschmann; Bernd Gruhn
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-25       Impact factor: 4.553

9.  Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1.

Authors:  Kevin N Heller; Frida Arrey; Peter Steinherz; Carol Portlock; Amy Chadburn; Kara Kelly; Christian Münz
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

10.  Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses.

Authors:  Ann M Moormann; Kevin N Heller; Kiprotich Chelimo; Paula Embury; Robert Ploutz-Snyder; Juliana A Otieno; Margaret Oduor; Christian Münz; Rosemary Rochford
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.